Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 42

1.

Minipigs as a neonatal animal model for tuberculosis vaccine efficacy testing.

Ramos L, Obregon-Henao A, Henao-Tamayo M, Bowen R, Izzo A, Lunney JK, Gonzalez-Juarrero M.

Vet Immunol Immunopathol. 2019 Sep;215:109884. doi: 10.1016/j.vetimm.2019.109884. Epub 2019 Jul 26.

PMID:
31420066
2.

Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis.

Orme IM, Henao-Tamayo MI.

Front Immunol. 2018 Mar 8;9:461. doi: 10.3389/fimmu.2018.00461. eCollection 2018. Review.

3.

Biology of clinical strains of Mycobacterium tuberculosis with varying levels of transmission.

Shanley CA, Henao-Tamayo MI, Bipin C, Mugasimangalam R, Verma D, Ordway DJ, Streicher EM, Orme IM.

Tuberculosis (Edinb). 2018 Mar;109:123-133. doi: 10.1016/j.tube.2018.02.003. Epub 2018 Feb 9.

4.

GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis.

King TH, Shanley CA, Guo Z, Bellgrau D, Rodell T, Furney S, Henao-Tamayo M, Orme IM.

Clin Vaccine Immunol. 2017 Dec 5;24(12). pii: e00245-17. doi: 10.1128/CVI.00245-17. Print 2017 Dec.

5.

The minipig as an animal model to study Mycobacterium tuberculosis infection and natural transmission.

Ramos L, Obregon-Henao A, Henao-Tamayo M, Bowen R, Lunney JK, Gonzalez-Juarrero M.

Tuberculosis (Edinb). 2017 Sep;106:91-98. doi: 10.1016/j.tube.2017.07.003. Epub 2017 Jul 14.

6.

The Memory Immune Response to Tuberculosis.

Kirman JR, Henao-Tamayo MI, Agger EM.

Microbiol Spectr. 2016 Dec;4(6). doi: 10.1128/microbiolspec.TBTB2-0009-2016. Review.

PMID:
28087940
7.

Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infection.

Henao-Tamayo MI, Obregón-Henao A, Arnett K, Shanley CA, Podell B, Orme IM, Ordway DJ.

J Leukoc Biol. 2016 Apr;99(4):605-17. doi: 10.1189/jlb.4A0614-308RR. Epub 2015 Nov 20.

8.

The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis.

Henao-Tamayo M, Shanley CA, Verma D, Zilavy A, Stapleton MC, Furney SK, Podell B, Orme IM.

PLoS One. 2015 Sep 14;10(9):e0136500. doi: 10.1371/journal.pone.0136500. eCollection 2015.

9.

Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models.

Obregón-Henao A, Arnett KA, Henao-Tamayo M, Massoudi L, Creissen E, Andries K, Lenaerts AJ, Ordway DJ.

Antimicrob Agents Chemother. 2015 Nov;59(11):6904-12. doi: 10.1128/AAC.00459-15. Epub 2015 Aug 24.

10.

Caspase-3-independent apoptotic pathways contribute to interleukin-32γ-mediated control of Mycobacterium tuberculosis infection in THP-1 cells.

Bai X, Kinney WH, Su WL, Bai A, Ovrutsky AR, Honda JR, Netea MG, Henao-Tamayo M, Ordway DJ, Dinarello CA, Chan ED.

BMC Microbiol. 2015 Feb 21;15:39. doi: 10.1186/s12866-015-0366-z.

11.

Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.

Bai X, Shang S, Henao-Tamayo M, Basaraba RJ, Ovrutsky AR, Matsuda JL, Takeda K, Chan MM, Dakhama A, Kinney WH, Trostel J, Bai A, Honda JR, Achcar R, Hartney J, Joosten LA, Kim SH, Orme I, Dinarello CA, Ordway DJ, Chan ED.

Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5111-6. doi: 10.1073/pnas.1424302112. Epub 2015 Mar 27.

12.

Functional drug screening reveals anticonvulsants as enhancers of mTOR-independent autophagic killing of Mycobacterium tuberculosis through inositol depletion.

Schiebler M, Brown K, Hegyi K, Newton SM, Renna M, Hepburn L, Klapholz C, Coulter S, Obregón-Henao A, Henao Tamayo M, Basaraba R, Kampmann B, Henry KM, Burgon J, Renshaw SA, Fleming A, Kay RR, Anderson KE, Hawkins PT, Ordway DJ, Rubinsztein DC, Floto RA.

EMBO Mol Med. 2015 Feb;7(2):127-39. doi: 10.15252/emmm.201404137.

13.

Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.

Henao-Tamayo M, Obregón-Henao A, Creissen E, Shanley C, Orme I, Ordway DJ.

Clin Vaccine Immunol. 2015 Jan;22(1):91-8. doi: 10.1128/CVI.00466-14. Epub 2014 Nov 12.

14.

Memory T cell subsets in tuberculosis: what should we be targeting?

Henao-Tamayo M, Ordway DJ, Orme IM.

Tuberculosis (Edinb). 2014 Sep;94(5):455-61. doi: 10.1016/j.tube.2014.05.001. Epub 2014 Jun 17. Review.

PMID:
24993316
15.

Increased severity of tuberculosis in Guinea pigs with type 2 diabetes: a model of diabetes-tuberculosis comorbidity.

Podell BK, Ackart DF, Obregon-Henao A, Eck SP, Henao-Tamayo M, Richardson M, Orme IM, Ordway DJ, Basaraba RJ.

Am J Pathol. 2014 Apr;184(4):1104-1118. doi: 10.1016/j.ajpath.2013.12.015. Epub 2014 Jan 31.

16.

Gr1(int)CD11b+ myeloid-derived suppressor cells in Mycobacterium tuberculosis infection.

Obregón-Henao A, Henao-Tamayo M, Orme IM, Ordway DJ.

PLoS One. 2013 Nov 1;8(11):e80669. doi: 10.1371/journal.pone.0080669. eCollection 2013.

17.

Metabolomic signatures in guinea pigs infected with epidemic-associated W-Beijing strains of Mycobacterium tuberculosis.

Somashekar BS, Amin AG, Tripathi P, MacKinnon N, Rithner CD, Shanley CA, Basaraba R, Henao-Tamayo M, Kato-Maeda M, Ramamoorthy A, Orme IM, Ordway DJ, Chatterjee D.

J Proteome Res. 2012 Oct 5;11(10):4873-84. doi: 10.1021/pr300345x. Epub 2012 Aug 30.

PMID:
22873951
18.

Beijing sublineages of Mycobacterium tuberculosis differ in pathogenicity in the guinea pig.

Kato-Maeda M, Shanley CA, Ackart D, Jarlsberg LG, Shang S, Obregon-Henao A, Harton M, Basaraba RJ, Henao-Tamayo M, Barrozo JC, Rose J, Kawamura LM, Coscolla M, Fofanov VY, Koshinsky H, Gagneux S, Hopewell PC, Ordway DJ, Orme IM.

Clin Vaccine Immunol. 2012 Aug;19(8):1227-37. doi: 10.1128/CVI.00250-12. Epub 2012 Jun 20.

19.

A mouse model of tuberculosis reinfection.

Henao-Tamayo M, Obregón-Henao A, Ordway DJ, Shang S, Duncan CG, Orme IM.

Tuberculosis (Edinb). 2012 May;92(3):211-7. doi: 10.1016/j.tube.2012.02.008. Epub 2012 Mar 17.

PMID:
22429719
20.

Drug treatment combined with BCG vaccination reduces disease reactivation in guinea pigs infected with Mycobacterium tuberculosis.

Shang S, Shanley CA, Caraway ML, Orme EA, Henao-Tamayo M, Hascall-Dove L, Ackart D, Orme IM, Ordway DJ, Basaraba RJ.

Vaccine. 2012 Feb 21;30(9):1572-82. doi: 10.1016/j.vaccine.2011.12.114. Epub 2012 Jan 11.

21.

Immune Responses of HIV-1 Tat Transgenic Mice to Mycobacterium Tuberculosis W-Beijing SA161.

Honda JR, Shang S, Shanley CA, Caraway ML, Henao-Tamayo M, Chan ED, Basaraba RJ, Orme IM, Ordway DJ, Flores SC.

Open AIDS J. 2011;5:86-95. doi: 10.2174/1874613601105010086. Epub 2011 Oct 19.

22.

Increased virulence of an epidemic strain of Mycobacterium massiliense in mice.

Shang S, Gibbs S, Henao-Tamayo M, Shanley CA, McDonnell G, Duarte RS, Ordway DJ, Jackson M.

PLoS One. 2011;6(9):e24726. doi: 10.1371/journal.pone.0024726. Epub 2011 Sep 12.

23.

A recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.

Sweeney KA, Dao DN, Goldberg MF, Hsu T, Venkataswamy MM, Henao-Tamayo M, Ordway D, Sellers RS, Jain P, Chen B, Chen M, Kim J, Lukose R, Chan J, Orme IM, Porcelli SA, Jacobs WR Jr.

Nat Med. 2011 Sep 4;17(10):1261-8. doi: 10.1038/nm.2420.

24.

Mycobacterium bovis BCG-mediated protection against W-Beijing strains of Mycobacterium tuberculosis is diminished concomitant with the emergence of regulatory T cells.

Ordway DJ, Shang S, Henao-Tamayo M, Obregon-Henao A, Nold L, Caraway M, Shanley CA, Basaraba RJ, Duncan CG, Orme IM.

Clin Vaccine Immunol. 2011 Sep;18(9):1527-35. doi: 10.1128/CVI.05127-11. Epub 2011 Jul 27.

25.

T lymphocyte surface expression of exhaustion markers as biomarkers of the efficacy of chemotherapy for tuberculosis.

Henao-Tamayo M, Irwin SM, Shang S, Ordway D, Orme IM.

Tuberculosis (Edinb). 2011 Jul;91(4):308-13. doi: 10.1016/j.tube.2011.04.001. Epub 2011 Apr 29.

26.

Cigarette smoke increases susceptibility to tuberculosis--evidence from in vivo and in vitro models.

Shang S, Ordway D, Henao-Tamayo M, Bai X, Oberley-Deegan R, Shanley C, Orme IM, Case S, Minor M, Ackart D, Hascall-Dove L, Ovrutsky AR, Kandasamy P, Voelker DR, Lambert C, Freed BM, Iseman MD, Basaraba RJ, Chan ED.

J Infect Dis. 2011 May 1;203(9):1240-8. doi: 10.1093/infdis/jir009. Epub 2011 Feb 28.

PMID:
21357942
27.

Activities of TMC207, rifampin, and pyrazinamide against Mycobacterium tuberculosis infection in guinea pigs.

Shang S, Shanley CA, Caraway ML, Orme EA, Henao-Tamayo M, Hascall-Dove L, Ackart D, Lenaerts AJ, Basaraba RJ, Orme IM, Ordway DJ.

Antimicrob Agents Chemother. 2011 Jan;55(1):124-31. doi: 10.1128/AAC.00978-10. Epub 2010 Oct 11.

28.

Evaluation of standard chemotherapy in the guinea pig model of tuberculosis.

Ordway DJ, Shanley CA, Caraway ML, Orme EA, Bucy DS, Hascall-Dove L, Henao-Tamayo M, Harton MR, Shang S, Ackart D, Kraft SL, Lenaerts AJ, Basaraba RJ, Orme IM.

Antimicrob Agents Chemother. 2010 May;54(5):1820-33. doi: 10.1128/AAC.01521-09. Epub 2010 Feb 16.

29.

Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis.

Henao-Tamayo MI, Ordway DJ, Irwin SM, Shang S, Shanley C, Orme IM.

Clin Vaccine Immunol. 2010 Apr;17(4):618-25. doi: 10.1128/CVI.00368-09. Epub 2010 Jan 27.

30.

Post-exposure vaccination against Mycobacterium tuberculosis.

Henao-Tamayo M, Palaniswamy GS, Smith EE, Shanley CA, Wang B, Orme IM, Basaraba RJ, DuTeau NM, Ordway D.

Tuberculosis (Edinb). 2009 Mar;89(2):142-8. doi: 10.1016/j.tube.2009.01.002. Epub 2009 Mar 4.

31.

Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens.

El Kasmi KC, Qualls JE, Pesce JT, Smith AM, Thompson RW, Henao-Tamayo M, Basaraba RJ, König T, Schleicher U, Koo MS, Kaplan G, Fitzgerald KA, Tuomanen EI, Orme IM, Kanneganti TD, Bogdan C, Wynn TA, Murray PJ.

Nat Immunol. 2008 Dec;9(12):1399-406. doi: 10.1038/ni.1671. Epub 2008 Nov 2.

32.

Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease.

Gonzalez-Juarrero M, Kingry LC, Ordway DJ, Henao-Tamayo M, Harton M, Basaraba RJ, Hanneman WH, Orme IM, Slayden RA.

Am J Respir Cell Mol Biol. 2009 Apr;40(4):398-409. doi: 10.1165/rcmb.2008-0248OC. Epub 2008 Sep 11.

33.

Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis.

Ordway D, Henao-Tamayo M, Shanley C, Smith EE, Palanisamy G, Wang B, Basaraba RJ, Orme IM.

Clin Vaccine Immunol. 2008 Aug;15(8):1248-58. doi: 10.1128/CVI.00019-08. Epub 2008 May 28.

34.

Animal model of Mycobacterium abscessus lung infection.

Ordway D, Henao-Tamayo M, Smith E, Shanley C, Harton M, Troudt J, Bai X, Basaraba RJ, Orme IM, Chan ED.

J Leukoc Biol. 2008 Jun;83(6):1502-11. doi: 10.1189/jlb.1007696. Epub 2008 Feb 29.

PMID:
18310351
35.

A mutant of Mycobacterium tuberculosis lacking the 19-kDa lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties.

Henao-Tamayo M, Junqueira-Kipnis AP, Ordway D, Gonzales-Juarrero M, Stewart GR, Young DB, Wilkinson RJ, Basaraba RJ, Orme IM.

Vaccine. 2007 Oct 10;25(41):7153-9. Epub 2007 Aug 13.

36.

XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability.

Ordway D, Higgins DM, Sanchez-Campillo J, Spencer JS, Henao-Tamayo M, Harton M, Orme IM, Gonzalez Juarrero M.

J Leukoc Biol. 2007 Nov;82(5):1221-9. Epub 2007 Aug 15.

PMID:
17699612
37.

The cellular immune response to Mycobacterium tuberculosis infection in the guinea pig.

Ordway D, Palanisamy G, Henao-Tamayo M, Smith EE, Shanley C, Orme IM, Basaraba RJ.

J Immunol. 2007 Aug 15;179(4):2532-41.

38.

A Toll-like receptor-2-directed fusion protein vaccine against tuberculosis.

Wang B, Henao-Tamayo M, Harton M, Ordway D, Shanley C, Basaraba RJ, Orme IM.

Clin Vaccine Immunol. 2007 Jul;14(7):902-6. Erratum in: Clin Vaccine Immunol. 2008 Sep;15(9):1495.

39.

The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation.

Ordway D, Henao-Tamayo M, Harton M, Palanisamy G, Troudt J, Shanley C, Basaraba RJ, Orme IM.

J Immunol. 2007 Jul 1;179(1):522-31.

40.

Enhanced macrophage activity in granulomatous lesions of immune mice challenged with Mycobacterium tuberculosis.

Ordway D, Harton M, Henao-Tamayo M, Montoya R, Orme IM, Gonzalez-Juarrero M.

J Immunol. 2006 Apr 15;176(8):4931-9.

42.

Interleukin-10 production by lung macrophages in CBA xid mutant mice infected with Mycobacterium tuberculosis.

Junqueira-Kipnis AP, Kipnis A, Henao Tamayo M, Harton M, Gonzalez Juarrero M, Basaraba RJ, Orme IM.

Immunology. 2005 Jun;115(2):246-52.

Supplemental Content

Loading ...
Support Center